HZNP stock: buy or sell?

HZNP stock price: $49.56 3.40% At close on May 22nd, 2020

Updated on:
May 22nd, 2020

5

After marking all time highs on May/22, Horizon Pharma rocketed 3.40% on May 22nd to $49.56. May 22nd was the 4th green session in a row, marking 7.16%.

Horizon Pharma Public Limited Company, a biopharmaceutical company, engages in identifying, developing, acquiring, and commercializing medicines for the treatment of orphan diseases, arthritis, pain, and inflammation and inflammatory diseases in the United States and internationally.

Should I buy HZNP stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Following a trading plan helps to make decisions easier, quicker and with less hesitations. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

Currently, 2 buy setups work for Horizon Pharma stock right now:

Buy setupElegible
New all-time highYes
New 52 week highYes
Price crossing up 200d MANo
100d MA crossing up 200d MANo

Is Horizon Pharma stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't detect any rating for HZNP stock for the last 30 days.

HZNP stock analysis

Daily outlook

After several days of continuous rises in past weeks, Horizon Pharma rocketed 3.40% to $49.56.

Shares of Horizon Pharma ended on May 22nd at $49.56 after topping to a new all time high ($49.81) and rocketed a superb 3.40%. Since price and SMA200d lines crossed up on April, HZNP climbed $19.94 (67.32%). HZNP shows a strong short term uptrend with several rising tops and rising bottoms. Since its last bottom on April 21st, HZNP climbed unceasignly breaking out to new all time highs.

HZNP stock chart (daily)

Weekly outlook

Horizon Pharma shares skyrocketed 5.29% this week and marked a new all time high at $49.81. This week was the fourth green week in a row.

Late March HZNP price bounced up over the SMA of 40 weeks that acted as support stopping new slides. This week, SMA10w and SMA20w crossed up triggering a rise of 5.29%.

HZNP stock chart (weekly)

HZNP stock price history

HZNP IPO was on July 28th, 2011 at $9.00 per share1. Since then, HZNP stock surged a 450.70%, with a yearly average of 56.30%. If you had invested $1,000 in HZNP stock in 2011, it would worth $4,507.00 today.

1: Adjusted price after possible price splits or reverse-splits.

HZNP stock historical price chart

HZNP stock reached all-time highs on May/22 with a price of $49.81.

HZNP stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last 30 days we have not detected any price forecast for Horizon Pharma stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Horizon Pharma presented amazing results for 2018-Q4 . Horizon Pharma skyrocketed Earnings per Share (EPS) by 24.10%, beating experts consensus of $0.54. Horizon Pharma posted $0.67.
HZNP earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.56n/a
2017-Q2-n/a-1.31n/a
2017-Q32017-11-060.220.2618.2%
2017-Q42018-02-280.220.2931.8%
2018-Q12018-05-090.110.03-72.7%
2018-Q22018-08-080.290.4865.5%
2018-Q32018-11-070.50.6530.0%
2018-Q42019-02-270.540.6724.1%
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Horizon Pharma annual sales skyrocketed an extraordinary 14.33% to $1,207.57 million USD from $1,056.23 marked in 2017. When comparing 2018 vs 2017, in line, profit margin (that is, the net income divided by revenues) rocketed a 31.88% to -6.14%.

HZNP annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$74 M-$-149.01 M-201.3%-
2014$297 M301.18%$-263.60 M-88.8%76.90%
2015$757 M154.94%$40 M5.2%-115.00%
2016$981 M29.60%$-166.83 M-17.0%-522.02%
2017$1,056 M7.66%$-401.59 M-38.0%140.71%
2018$1,208 M14.33%$-74.19 M-6.1%-81.53%

Quarterly financial results

Horizon Pharma posted $355.54 M in sales for 2018-Q4, a 9.29% up compared to previous quarter. Reported quarter earnings marked $89.95 M with a profit margin of 25.30%. Profit margin climbed a 17.30% compared to previous quarter when profit margin was 8.00%. When comparing sales to same quarter last year, Horizon Pharma sales marked a dazzling increase and boosted a 29.66%. Looking back to recent quarterly results, Horizon Pharma posted 3 negative quarters in a row.
HZNP quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$221 M-$-90.57 M-41.0%-
2017-Q2$290 M31.08%$-209.54 M-72.4%131.36%
2017-Q3$272 M-6.17%$-63.97 M-23.5%-69.47%
2017-Q4$274 M0.95%$-46.45 M-16.9%-27.39%
2018-Q1$224 M-18.36%$-157.33 M-70.3%238.72%
2018-Q2$303 M35.27%$-32.84 M-10.8%-79.13%
2018-Q3$325 M7.42%$26.03 M8.0%-179.27%
2018-Q4$356 M9.29%$89.95 M25.3%245.55%

Horizon Pharma ownership

Having a look at Horizon Pharma ownership structure gives valuable information about the company and its governance (insider ownership) or the amount of investors that are on the short side.

Horizon Pharma shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 1.31% of all shares.

Bearish positions for HZNP stock account 0.00%, no big difference from last month.

For a better understanding, the following table shows ownership data compared to other related stocks:

HZNP
Market cap$9.5 B
Total shares190.8 M
Float shares177.3 M
  - Institutional holdings (%)91.7%
  - Insider holdings (%)1.3%
Shares in short selling0.0%

HZNP summary

Friday, May 22nd, 2020
Open$47.82
Close$49.56
Day range$47.73 - $49.81
Previous close$47.93
Session gain3.40%
Average true range$2.33
50d mov avg$34.88
100d mov avg$35.23
200d mov avg$32.26
Daily patternlb03c
Weekly pattern lb06c

Horizon Pharma performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Horizon Pharma against in the following table:
Stock3m6m12m
HZNPHorizon Pharma39.61%57.08%99.60%

Horizon Pharma competitors

Unfortunately, we could not find any public company that could be defined as Horizon Pharma competitor. This doesn't mean Horizon Pharma does not have any competitor in the market, it's just we could not detected it.